Ganesh Raveendran, MD
Clinics and Surgery Center909 Fulton St. SE Floor 3
Minneapolis MN 55455
Sees Patients at:
Philosophy of Care:I desire to be an innovative leader in the field of general cardiac care and interventional cardiology and am dedicated to the highest standard of care to restore patients to optimal health and quality of life. I approach all relationships with integrity and strive to deliver superior service to patients and referring physicians.
Mpls. St. Paul Magazine "Top Doctor" - (2012, 2014)
Educational Excellence Award (2010) Department of Medicine, University of Minnesota
Tara L. Rasmussen, Ph.D., Ganesh Raveendran, M.D., Jianyi Zhang, M.D., Ph.D. and Daniel J. Garry, M.D., Ph.D. Getting to the heart of myocardial stem cells and cell therapy. Circulation in print.
Robert Wilson, Ganesh Raveendran: What’s good for the Gander is now good for the goose. Journal of the American College of Cardiology. 2008; 51 (24); 2321-2322.
Ganesh Raveendran, Henry Ting, Patricia Best, David Holmes, Ryan Lenon, Mandeep Singh, Malcolm Bell, Kirsten Long, Charanjit Rihal: Eptifibatide and Abciximab were equivalent as adjunctive therapy for primary percutaneous coronary intervention in an unselected population with acute myocardial infarction. Mayo Clin Proc. 2007;82:196-202.
Kirsten Long, Henry Ting, Erin McMurty, Ryan Lennon, Lavon Hammes, Douglus Wood, David Holmes, Ganesh Raveendran, Charanjit Rihal: A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions. Value Health. 2008 May-Jun;11(3):462-9.
Henry Ting, Ganesh Raveendran, Ryan Lennon, Kirsten Hall, Mandeep Singh, Douglas Wood, Bernard Gersh, Charanjit Rihal, David Holmes: A Total of 1,007 Percutaneous Coronary Interventions without Onsite Cardiac Surgery. Acute and Long-Term Outcomes. J Am Coll Cardiol 2006; 47:1713-21).
Panetta CJ, Fasseas P, Raveendran G, Garratt KN: Pseudoperforation during kissing balloon angioplasty. Catheter Cardiovascular Interv. 2004, 63(3):290-3.